University Hospitals Bristol And Weston Nhs Foundation Trust
Clinical trials sponsored by University Hospitals Bristol And Weston Nhs Foundation Trust, explained in plain language.
-
Head-to-Head: which chemo works better for HER2-Negative breast cancer?
Disease control CompletedThis trial compares two chemotherapy drugs—cabazitaxel given every three weeks versus paclitaxel given weekly—as a first treatment for HER2-negative metastatic breast cancer. About 90 to 160 participants receive 18 weeks of one of the two drugs. The main goal is to see which drug…
Phase: PHASE2 • Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New chemo cocktail shows promise for invasive bladder cancer
Disease control CompletedThis phase 2 trial tested a combination of two chemotherapy drugs, cabazitaxel and cisplatin, given before surgery to remove the bladder in 28 patients with invasive bladder cancer. The goal was to see if the drugs could shrink the tumor enough to improve outcomes. The study also…
Phase: PHASE2 • Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC